Skip to main content
. 2021 Dec 17;43(3):2266–2275. doi: 10.3390/cimb43030159

Figure 3.

Figure 3

Validation of the SDHB c.287-2A>G mutation with Sanger sequencing in the recurrent tumor. (a) Exome sequencing data (variant nucleotides are marked by red color, forward and reverse reads present as pink and blue horizontal lines, respectively). (b) Sanger sequencing chromatogram.